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ABSTRACT 
Benzothiopyran is a heterocyclic compound which contains sulphur as a heteroatom which is responsible for biological and 
pharmacological activity. Changing heterocyclic ring size will generate derivatives that are not only retained the calcium channel 
blocking activity but also resulted in several compounds that were more active than diltiazem. A receptor-binding model identifying 
the benzene ring as a lipophilic group that facilitates transport into the channel and the absolute stereochemistry for the selective 
binding.  Benzothiopyran nucleus is similar to the benzothiazepine nucleuses which are used as calcium channel blockers. In these 
synthesis series, benzothiazepine nucleus containing nitrogen atom which is replace by bioisosterism of nitrogen. 
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INTRODUCTION:  
Calcium channel blocking agents (CCBs) inhibit the 
movement of calcium ions across the cell membrane by 
blocking the L-type (slow) calcium ion channel. This 
blockade reduces contraction of both smooth and cardiac 
muscle, and cells within the sinoatrial (SA) and 
atrioventricular (AV) nodes
1-3
.
 
MATERIAL AND METHODS: 
Synthesis of benzothiopyran derivatives The present 
work comprises synthesis of the benzothiopyran 
derivatives. The steps involved in the synthesis include 
the synthesis. 
 
Step- I 
CH CH
NO2
CHO
NH2
CH CH CHO
SnCl2/ HCl
Ethanol
3-(2-nitrophenyl) prop-2-enal 3-(2-aminophenyl)   prop-2-enal  
Step-II 
NH2
CH CH CHO
NaNO2 /HCl
N2Cl
CH CH CHO
3-(2-aminophenyl)   prop-2-enal Intermediate I
SH
CH CH CHO
KSH/HCl
3-(2-sulfanylphenyl) prop-2-enal
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Step-III 
SH
CH CH CHO
3-(2-sulfanylphenyl) prop-2-enal
SH
CH CH C
OCH3
H
OH
S
Cyclization
- H2O
OCH3
2-methoxy-2H-thiochromene
Intermediate II
CH3OH/HCl
 
Step-IV 
S
S
Cl
OH
OCH3
HO -Cl
OCH3
2-methoxy-2H-thiochromene
3-chloro-2-methoxy-3,4 dihydro-
2H-1-benzothiopyran-4-ol  
Step-V 
S
OCOCH3
Cl
RS
Cl
OH
OCH3
3-chloro-2-methoxy-3,4 dihydro-
2H-1-benzothiopyran-4-ol
Acylation
3-chloro-2-methoxy-3,4 dihydrothiopyran-
4yl acetate  
RESULTS AND DISCUSSION: 
Step Melting 
point 
TLC 
1
HNMR IR SPECTRA (KBr) cm
-1
 
STEP- I 232
0
C Methanol: Ethyl 
acetate (9:1) 
Rf  for 3-(2-
nitrophenyl) prop-2-
enal  =0.8 
Rf  for 3-(2-
aminophenyl)   prop-
2-enal = 0.6 
δ 3.03(s, 2H, NH2), 6.66 (d, 
1H, -CH=C-), 6.68 (dd, 
1H,aromatic  proton, ortho to 
amino group), 7.74 (td,1H, 
aromatic  proton, para to 
amino group), 7.66 (dd, 1H, 
aromatic  proton, meta to 
amino group), 7.80 (td,1H, 
aromatic  proton, meta to 
amino group), 8.12(d, 1H,-
C=CH-), 9.77 (s,1H, -CHO). 
3228 (N-H Stretch of amine  
group), 3049.25 (C-H Stretch of 
aromatic ring),2975.96  ( C-H 
Stretch of  alkene)2736.80 (C-H 
Stretch of -CHO) 1680.56  (C=O 
Stretch of -CHO ) 1625.81 (C=C 
Stretch of alkene), 1610.43 
and1442.66(C=C Stretch of 
aromatic ring), 1569.95 cm
-1  
(N-H 
bending of amine group), 1172.64 
(C-N Stretch of amine and aromatic 
carbon), 1037.63- 977.84 (C=C 
bending (oop) of alkene ), 806.19 
(N-H bending (oop) of amine 
group),738.69 (aromatic =C-H 
bending (oop) for ortho-
substitution. 
STEP-2 248
0
C Methanol: Ethyl 
acetate (9:1) 
 Rf  for 3-(2-
aminophenyl) prop-2-
enal (1) = 0.5  
Rf  for 3-(2-
sulfanylphenyl) prop-
2-enal  (2) = 0.29 
δ 3.47 (s, 1H, SH), 6.73 (td, 
1H, Jo = 7.36 Hz,aromatic  
proton, meta to SH group), 
7.65 (d, 1H, -C=CH-), 7.77 
(dd, 1H,aromatic  proton, meta 
to SH group), 7.81 (td, 
1H,aromatic  proton,  para to 
SH group), 7.92 
(dd,1H, aromatic  proton, 
ortho to SH group), 8.02 (d, 
1H, -CH=C-), 9.78 (s,1H, -
CHO). 
3045.11 (C-H Stretch of aromatic 
ring) , 2925.81 ( C-H Stretch of  
alkene), 2735.13 (C-H Stretch of -
CHO), 1681.81 (C=O Stretch of -
CHO), 1618.17 (C=C Stretch of 
alkene), 1519.80 and 1456.16 (C=C 
Stretch of aromatic ring), 671.18 
(C-S Stretch of mercapto and 
aromatic carbon), 1035.70- 964.34 ( 
C=C bending (oop) of 
alkene), 746.40 (aromatic =C-H 
bending (oop) for ortho-
substitution). 
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STEP -3 250-
252°C 
Solvent System = 
Ethyl acetate : 
Methanol  ( 8   :  2) 
Rf   Value for 
Intermediate 3-(2-
sulfanylphenyl)prop-
2-enal = 0.43 
Rf Value for 
Intermediate 2-
methoxy-2H-
thiochromene = 0.54 
δ 3.54 (s,3H, O-CH3), 5.71 (d, 
1H, -S-CH-),6.72(dd, 1H, -S-
CH-CH-), 7.65(d,1H,-S-CH-
CH=CH-), 7.79(td, 1H, 
aromatic proton), 
7.81(dd,1H,aromatic  proton), 
8.06 (td, 1H, aromatic  proton 
), 8.10(dd,1H, Jo = 
7.54,aromatic  proton). 
3047.48 (C-H Stretch of aromatic 
ring) , 2862.96 ( C-H Stretch of  
alkane),  1595.46 and 1416.10 (C=C 
Stretch of aromatic ring), 1440.51 
and 1375.08 (C-H bending of 
alkane), 1224.71 and 1043.70(C-O-
C Stretch of methoxy),1124.12 (C-
O Stretch of methoxy ),740.61 
(aromatic =C-H bending (oop) for 
ortho-substitution),785.25 (C-S 
Stretch of mercapto and aromatic 
carbon) 
STEP- 4 180- 
185 °C 
Solvent System = 
Methanol : 
Chloroform (4  : 6) 
Rf   Value for  2-
methoxy-2H-
thiochromene  = 0.56 
Rf Value for  3-
chloro-2-methoxy-3,4 
dihydro-2H-1-
benzothiopyran-4-ol= 
0.32 
δ 2.19 (s,1H, -OH), 3.29(s, 
3H, -O-CH3), 4.49(d,1H, -S-
CH-CH-CH-), 4.56 (d, -S-CH-
),6.88 (td, 1H, aromatic 
proton), 7.01 (dd, 1H,aromatic 
proton), 7.11 (td, 1H, aromatic 
proton), 7.48 (dd, 1H, Jo = 
6.76 Hz, aromatic proton). 
3343.34(O-H Stretch of hydroxyl 
group), 2994.28 (C-H Stretch of 
aromatic ring) , 2856.38 ( C-H 
Stretch of  alkane), 1591.16 and 
1512.08 (C=C Stretch of aromatic 
ring), 1452.30 and 1392.51 (C-H 
bending of alkane), 1150.24 (C-O 
Stretch of alcohol),1260.29 and 
1047.31(C-O-C Stretch of 
methoxy),1101.28 (C-O Stretch of 
methoxy), 1O47.81 ( C-Cl Stretch 
of Ar-chloride), 757.83 (aromatic 
=C-H bending (oop) for ortho-
substitution),669.61 (C-S Stretch of 
mercapto and aromatic carbon). 
STEP- 5 180- 
185 °C 
Solvent System = 
Methanol  : 
Chloroform (4  : 6) 
Rf  Value for  3-
chloro-2-methoxy-3,4 
dihydro-2H-1-
benzothiopyran-4-ol 
= 0.62 
Rf Value for  3-
chloro-2-methoxy-3,4 
dihydrothiopyran-4yl 
acetate = 0.46 
δ 2.12(s,3H, -C-(=O) CH3), 
3.63(s, 3H, -O-CH3), 
5.51(d,1H, -S-CH-CH-CH-), 
5.98(d ,-S-CH-), s6.97( dd, 
1H, aromatic proton), 
7.36(dd,1H,aromatic proton), 
7.56 (dd, 1H, aromatic 
proton), 7.59 (d,1H, aromatic 
proton). 
1762.82 (C=O Stretch of ester 
group), 3082.28 (C-H Stretch of 
aromatic ring) , 2864.09 ( C-H 
Stretch of  alkane ), 1627.81 and 
1535.23 (C=C Stretch of aromatic 
ring), 1448.44 and 1388.65 (C-H 
bending of alkane ), 1147.07 (C-O 
Stretch of alcohol),1147.07 and 
1022.31(C-O-C Stretch of 
methoxy),1147.81 (C-O Stretch of 
methoxy), 1O74.81 ( C-Cl Stretch 
of Ar-chloride), 761.83 (aromatic 
=C-H bending (oop) for ortho-
substitution),667.32 (C-S Stretch of 
mercapto and aromatic carbon). 
 
Pharmacological Evaluation 
The pharmacological approach for evaluation of calcium channel blocking activity of compounds 5A, 5B derivation 
guinea-pig ileum by concentration response curve. 
Table 2: Effect of Compounds (5A-2) in the Concentration Response Curves 
Dose Concentration (Mm) Mean± S.E.M. (Compound 5a-2) 
 KCl 80 1.53 
I 60 1.93 
II 80 1.43 
III 100 2.08 
amlodipine 10 2.15 
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CONCLUSION: 
The main objective of present study was synthesis of 
novel benzothiopyran derivatives for treatment of 
cardiovascular disease. In the current research work, 
substituted 3-chloro-3,4-dihydrothiochromen-4-one and 
3-chloro-3,4-dihydro-2H-thiochromen-4yl acetate 
derivatives (5A-5B) were synthesized, with elaborate 
characterization by spectral data. Synthesize compounds 
were obtained in satisfactory yield and were 
characterized by TLC, FT-IR, 
1
HNMR. In 
pharmacological evaluation, synthesize compounds 5A-
1, 5A-2, 5B-1, 5B-2 gave in-vitro Calcium channel 
antagonist activity. On the basis of above study it is 
suggest that substituted 3-chloro-3,4-
dihydrothiochromen-4-one and 3-chloro-3,4-dihydro-
2H-thiochromen-4yl acetate derivatives  having 
significant calcium channel antagonistic action agents, 
KCl induce contraction. 
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